Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.

Saved in:
Bibliographic Details
Title: Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin αvβ3+ Cancers.
Authors: Reddy JP; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Yu Z; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Shepard RM; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Von Schalscha T; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Clague RA; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Peixoto BP; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., McCormack SJ; Alpha Beta Therapeutics, Camden, Delaware., Onaitis MW; Division of Cardiothoracic Surgery, Department of Surgery and Moores Cancer Center, University of California, San Diego, San Diego, California., Weis SM; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Cheresh DA; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California., Wettersten HI; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, San Diego, California.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 02; Vol. 25 (3), pp. 448-456.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-25-0300